Intercept Pharmaceuticals, Inc. (ICPT) posted a loss of $4.84 per share in the fourth quarter of 2016, wider than the Zacks Consensus Estimate of a loss of $3.58.
- The Wall Street Journal•2 days ago
Declines in biotechnology shares dragged down the Nasdaq Composite, pressuring an index that has soared so far this year. The Dow Jones Industrial Average climbed, setting another high.
- Thomson Reuters StreetEvents•2 days ago
Q4 2016 Intercept Pharmaceuticals Inc Earnings Call
ICPT : Summary for Intercept Pharmaceuticals, Inc. - Yahoo Finance
Intercept Pharmaceuticals, Inc. (ICPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||114.50 x 100|
|Day's Range||114.93 - 119.74|
|52 Week Range||96.63 - 177.93|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-7.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|